Ducroq Joffrey, Rouet René, Sallé Laurent, Puddu Paolo Emilio, Repessé Yohann, Ghadanfar Mathieu, Ducouret Pierre, Gérard Jean-Louis
Laboratoire d'Anesthésiologie Expérimentale et de Physiologie Cellulaire E3212, University of Caen, France.
Eur J Pharmacol. 2006 Feb 27;532(3):279-89. doi: 10.1016/j.ejphar.2005.12.083. Epub 2006 Feb 14.
To evaluate class III effects of clinically relevant concentrations of dofetilide (5 and 10 nmol/l) and the effects of extracellular potassium [K+]o modulation of arrhythmias onset at the level of the "border zone," we used a previously reported in vitro model whereby normoxic and ischemic/reperfused zones were studied. Guinea-pig right ventricular strips (driven at 1 Hz at 36.5+/-0.5 degrees C) were superfused with Tyrode's solution in oxygenated (HCO3- 25 mmol/l, K+ 4 mmol/l, pH 7.35+/-0.05, glucose 5.5 mmol/l: normal zone) and ischemia-simulating conditions (HCO3- 9 mmol/l, pH 6.90+/-0.05, no oxygen and no glucose: altered zone) having either [K+]o 4 (n=20), 8 (n=20) or 12 (n=20) mmol/l. Action potentials in normal and altered zones were recorded simultaneously during 30 min of simulated-ischemia and after 30 min of reperfusion with oxygenated Tyrode's solution. Each preparation served as control for successive phases of dofetilide studies (at 5 and 10 nmol/l) and action potential values were normalized to those present at the beginning of the experiment. During simulated-ischemia, the higher the [K+]o the worse were action potential changes, although full recovery was seen upon 30 min of reperfusion in all [K+]o groups. A high incidence of ischemia/reperfusion arrhythmias was observed in 4 and 12 mmol/l [K+]o groups as opposed to a low incidence of arrhythmias in 8 mmol/l [K+]o group. Dofetilide at 5 and 10 nmol/l with all [K+]o explored: (i) exhibited class III effects, (ii) was effective (or neutral) against ventricular arrhythmias during both simulated-ischemia and reperfusion, and (iii) did not globally increase the dispersion of action potential durations between normal and altered zones. Different arrhythmogenic mechanisms are involved in this model at different [K+]o with 8 mmol/l providing relative protection. Class III effects of dofetilide are evident in the normal zone when in the ischemic-like zone [K+]o ranges from 4 to 12 mmol/l. Thus dofetilide did not increase dispersion of repolarization and had either an antiarrhythmic or a neutral effect during ischemia/reperfusion.
为了评估临床相关浓度的多非利特(5和10纳摩尔/升)的III类效应,以及细胞外钾离子浓度[K+]o调节“边缘区”心律失常发生的效应,我们使用了先前报道的体外模型,研究常氧区和缺血/再灌注区。豚鼠右心室条带(在36.5±0.5摄氏度下以1赫兹驱动)在含氧(碳酸氢根25毫摩尔/升、钾离子4毫摩尔/升、pH 7.35±0.05、葡萄糖5.5毫摩尔/升:正常区)和模拟缺血条件(碳酸氢根9毫摩尔/升、pH 6.90±0.05、无氧且无葡萄糖:改变区)下用台氏液灌流,[K+]o分别为4(n = 20)、8(n = 20)或12(n = 20)毫摩尔/升。在30分钟的模拟缺血期间以及用含氧台氏液再灌注30分钟后,同时记录正常区和改变区的动作电位。每个标本用作多非利特研究(5和10纳摩尔/升)连续阶段的对照,动作电位值以实验开始时的值进行归一化。在模拟缺血期间,[K+]o越高,动作电位变化越差,尽管在所有[K+]o组中再灌注30分钟后均可见完全恢复。在[K+]o为4和12毫摩尔/升的组中观察到缺血/再灌注心律失常的发生率较高,而在[K+]o为8毫摩尔/升的组中心律失常的发生率较低。在所有研究的[K+]o条件下,5和10纳摩尔/升的多非利特:(i)表现出III类效应,(ii)在模拟缺血和再灌注期间对室性心律失常有效(或呈中性),(iii)未整体增加正常区和改变区之间动作电位持续时间的离散度。在该模型中,不同的[K+]o涉及不同的致心律失常机制,8毫摩尔/升可提供相对保护。当在缺血样区[K+]o范围为4至12毫摩尔/升时,多非利特在正常区的III类效应明显。因此,多非利特在缺血/再灌注期间不会增加复极离散度,并且具有抗心律失常或中性作用。